JOST Werke (JST) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Q3 2024 saw a soft market environment with significant declines in key regions, but operational activity remained high, including strategic acquisitions and plant consolidations.
The acquisition of Hyva Group was announced, expanding the portfolio and strengthening the position in hydraulic tipping cylinders and Asian markets, positioning for growth in off-highway and global presence.
Continued localization and expansion in Brazil, consolidation of manufacturing sites in China and North America, and operational excellence initiatives supported profitability.
R&D investments accelerated, focusing on innovation and transformation in transport and agriculture, with strategic partnerships such as Trailer Dynamics and Fernride.
Free cash flow and working capital management remained strong, keeping leverage at 1.0x and supporting shareholder value.
Financial highlights
Q3 2024 sales reached €246.3 million, including €14 million from recent M&A; adjusted EBIT was €26.5 million with a margin of 10.8%.
Free cash flow for the first nine months was €83.4 million; leverage remained at 1.0x EBITDA.
Adjusted EPS for the nine months was €4.04; adjusted net earnings to sales ratio stood at 7.1%.
Organic sales declined 20% year-over-year, with transport down 22.7% and agriculture up 18.8% due to acquisitions.
EBIT margin decreased from 11.4% to 10.8% year-over-year.
Outlook and guidance
Full-year 2024 sales expected to be down 15% year-over-year, with EBIT margin between 10.5% and 11%.
CapEx projected at 2.5–2.9% of sales; working capital to remain below 19% of sales.
No significant sequential improvement expected in Q4; recovery in India and agriculture anticipated in the second half of 2025.
Hyva acquisition expected to close in Q1 2025, with integration preparations underway.
Latest events from JOST Werke
- Margins and cash flow improved despite sales decline; 2024 guidance confirmed.JST
Q2 20248 Jul 2026 - Record Q1 2026 sales and margin gains, driven by Hyva synergies and organic growth.JST
Q1 202613 May 2026 - Sales up 44% and adjusted EBIT up 29% in 2025, with further gains targeted for 2026.JST
Q4 202529 Mar 2026 - Strong 2025 growth, digital innovation, and Hyva integration drive ambitious 2030 targets.JST
Investor presentation5 Mar 2026 - Acquisitions and expansion add €100m in sales and boost agricultural market reach.JST
Investor Update22 Jan 2026 - Targets €2B+ sales, €10 EPS, and 10–12% EBIT margin by 2030, driven by innovation and M&A.JST
CMD 202421 Jan 2026 - Acquisition targets EUR 23–28m synergies, expands global reach, and closes in Q4 2024.JST
M&A Announcement20 Jan 2026 - Hyva acquisition to drive 50–60% sales growth and margin expansion in 2025.JST
Q4 202417 Dec 2025 - Q2 2025 sales up 31% on Hyva deal, with 2025 outlook reaffirmed despite margin pressure.JST
Q2 202523 Nov 2025